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Background: Although there have been several studies about the relationship between alcohol or smoking 
and lower urinary tracts symptoms (LUTS). This study aimed to investigate the association between alcohol 
or smoking and severity of LUTS in men, as alcohol intake and cigarette smoking is important modifiable 
lifestyle factors for LUTS. 
Methods: A cross-sectional analysis has been performed and a total of 86,707 participants in Korean 
Community Health Survey were included for final analysis. The adjusted odds ratio (OR) or coefficient with 
95% confidence interval (CI) estimates were described to show the association between alcohol consumption 
or cigarette smoking and LUTS. 
Results: Among the total subjects, 77,398 (89.3%), 7,532 (8.7%), and 1,777 (2.0%) had mild, moderate, 
and severe symptoms, respectively, according to International Prostate Symptom Score (IPSS) grade. Those 
who drank alcohol at least once per month were significantly associated with decreased risk of having the 
worst IPSS grade (OR: 0.80, 95% CI: 0.68 to 0.93). Those who smoked in the past but currently quitted 
and those who were daily smokers showed significantly increased risk of having the worst IPSS grade (past 
smoker, OR: 1.26, 95% CI: 1.14 to 1.39; daily smoker, OR: 1.21, 95% CI: 1.10 to 1.34). For nocturia, daily 
smoking showed positive effect (OR: 0.79, 95% CI: 0.75 to 0.84) whereas heavy alcohol drinking showed 
negative effect (OR: 1.22, 95% CI: 1.14 to 1.32)
Conclusions: Alcohol showed positive effect on LUTS except nocturia whereas cigarette smoking had 
negative effect on LUTS except nocturia. Daily smoking showed positive effect on nocturia whereas heavy 
alcohol drinking showed negative effect on nocturia.
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Introduction
Traditionally, male lower urinary tract symptoms (LUTS) 
has been regarded as main problem of benign prostate 
hyperplasia (BPH) while female LUTS has been regards 
as overactive bladder (OAB). However, there are emerging 
evidences showing that not only biological factors of BPH 
and OAB, but also modifiable lifestyle factors could affect 
LUTS (1,2). Constructing changes in these modifiable 
lifestyle factors are important because there could be a 
potential treatment to control non-urological origin. 
However, only a few studies have focused on the efficacy 
of changing modifiable lifestyle factors including water 
restriction and weight loss in relation with nocturia and 
stress urinary incontinence (2-5). 
The main reason for few studies on the efficacy of 
changing modifiable lifestyle factors by prospective trials 
lies on inconsistent results from many observational 
studies. Before medication treatment, patients are generally 
educated to modify their lifestyle factors including changing 
volume of fluid intake, less caffeine, and less alcohol (1). 
However, these recommendations could only be adopted 
by limited portion of patients with LUTS. For better and 
broader application of changing lifestyle factors, more 
reliable evidences are needed. 
Among different lifestyle factors, cigarette smoking 
and alcohol drinking have shown inconsistent results 
regarding their effects on LUTS. Recently, one systematic 
review study has concluded that modest alcohol intake is 
a favorable factor for BPH/LUTS (2). However, excessive 
alcohol intake could lead to worse LUTS compared than 
less alcohol intake (2). About the relationship between 
cigarette smoking and LUTS, conclusion could not be 
made due to too few studies and inconsistent results (2). 
Considering the importance of cigarette smoking and 
alcohol intake for general health of our entire body, more 
objective studies are needed using large population sample 
to validate their relationships with LUTS. The objective 
of the present study was to investigate the relationship of 




This study used data obtained from the 2011 Korean 
Community Health Survey (KCHS). The KCHS is a 
nationwide public health survey annually conducted 
since 2008 by the Korean Centers for Disease Control 
and Prevention. The purpose of KCHS is to estimate 
community-based health statistics, morbidity, and 
prevalence of diseases among Korean adults. The KCHS 
adopted a multi-stage sampling design to ensure that 
the sampling unit was representative of the nation’s 
population. In the first stage, a primary sampling unit 
(district, town, and village) was extracted according to the 
number of households in each of the smallest governmental 
administrative units. A probability proportionate to the 
size sampling method was used when extracting samples. 
In the second stage, average of five sample households was 
extracted using systematic sampling methods at selected 
sampling point and every member of a household who was 
19 years or older was interviewed. This study was ultimately 
carried out using data from 86,707 subjects after excluding 
142,519 respondents who were females (N=126,209), 
who reported currently receiving treatment with prostatic 
hyperplasia (N=4,745) to prevent bias that might affect 
LUTS, and who had missing data for International Prostate 
Symptom Score (IPSS), dietary behavior variables, or 
covariates (N=11,565) from 229,226 participants originally 
included in the 2011 KCHS (Figure 1).
Variables and measurements
This study measured the LUTS of survey participants 
based on responses from the Korean version of IPSS 
Questionnaire on KCHS, one of the most widely used tools 
for evaluating LUTS. As independent variables, frequency 
of alcohol consumption and smoking status were measured 
by self-reported questionnaires. Alcohol consumption 
frequency was classified into “non-drinker”, “drink less than 
once per month”, “drink two to four times per month”, 
“drink two to three times per week”, and “drink four or 
more times per week”. Smoking status was determined by 
four categories: daily smoker, non-daily smoker, former 
smoker (smoked in the past but currently quitted), and 
never smoker (individuals who had smoked fewer than 100 
cigarettes in their lifetime). Dependent variables were IPSS 
grade {mild: IPSS total [0–7], moderate [8–19], severe [20–
35]}, IPSS voiding [sum of IPSS Q1 (incomplete emptying), 
Q3 (intermittency), Q5 (weak stream), Q6 (straining); 5 or 
higher score categorized as having symptoms], IPSS storage 
[sum of IPSS Q2 (frequency), Q4 (urgency), Q7 (nocturia); 
4 or higher score categorized as having symptoms], and 
nocturia (IPSS Q7; 1 or higher score categorized as having 
symptoms). 
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Socio-demographic factors and comorbidities were 
considered as covariates. Socio-demographic variables 
included age, marital status, education level, household 
income, and residence. Age was divided into “19–29”, 
“30–39”, “40–49”, “50–59”, “60–69”, “70–79”, “80–89”, 
and “90 or higher”. Marital status was classified into 
“married”, “separated, divorced, or widowed”, and “never 
married”. Education level was classified into “elementary 
school graduate or lower”, “middle school graduate”, 
“high school graduate”, and “college graduate or higher”. 
Household income was divided according to quartiles. 
Residence was based on 16 governmental administrative 
districts and assigned as “capital” (Seoul), “urban” 
(6 metropolitan cities were included; Busan, Daegu, 
Incheon, Gwangju, Daejeon, and Ulsan), or “rural” (rest 
of capital and urban regions were included: Gyeonggi, 
Gangwon, Chungbuk, Chungnam, Chungbuk, Chungnam, 
Jeonbuk, Jeonnam, Gyeongbuk, Gyeongnam, and Jeju). 
Comorbidities considered hypertension, diabetes mellitus, 
and dyslipidemia, the most prevalent chronic diseases in 
Korean adults. They were determined based on physician’s 
diagnosis.
Statistical analysis
Descriptive analysis was performed to summarize LUTS 
and socio-demographic characteristics of the study 
population. The frequency and percentage by IPSS grade 
were reported. To analyze group differences, a Chi-squared 
test was conducted. Ordinal logistic regression (for the 
IPSS grade) and binomial logistic regression (for the IPSS 
voiding, storage, and nocturia symptoms) were performed 
to identify the relationship between LUTS measured by 
IPSS and alcohol consumption or smoking among Korean 
male adults after controlling for independent variables and 
covariates. Adjusted odds ratio (OR) with 95% confidence 
interval (CI) estimates were reported and threshold for 
statistical significance was set at 5% (two-tailed). All analysis 
applied benchmark weight provided from KCHS to adjust 
for complex sampling design to produce reliable design-
based estimates and ensure national representativeness. 
Data were analyzed in Stata version 14.2 (StataCorp LP, 
College Station, TX, USA).
Ethics statement
Procedures of this study were reviewed and approved by the 
Institutional Review Board of Soonchunhyang University 
Seoul Hospital with a waiver for informed consent (2018-
12-011). KCHS data are openly accessible at national 
public repository (http://chs.cdc.go.kr). There were no 
confidentiality risks to participants of this study because all 
KCHS data were deidentified.
Results
Table 1 summarizes socio-demographic and LUTS 
characteristics of study subjects. Of a total of 86,707 study 
subjects, 77,398 (89.3%), 7,532 (8.7%), and 1,777 (2.0%) 
had mild, moderate, and severe symptoms, respectively, 
according to IPSS grade. Those who were older, separated, 
divorced or widowed in marital status, with lower education 
level or household income, residing in rural region, having 
hypertension, diabetes mellitus, or dyslipidemia, smoked 
in past but currently quitted, non-drinker or drinking four 
or more times per week tended to be have worse condition 
based on IPSS grade compared to their counterparts. 
The distribution of study subjects by IPSS grade showed 
Figure 1 Schematic diagram of the study subject selection.
A 229,226 individuals who participated in 2011 Korean Community Health Survey
Finally 86,707 participants were included in the study
Exclusions (N=142,519): participants met at least one criterion for exclusion
- Female (N=126,209)
- Currently receiving treatment with prostatic hyperplasia (N=4,745)
- Missing information in International Prostate Symptom Score, independent 
variable, or covariates (N=11,565)
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Pearson χ2 P valueMild Moderate Severe
N % N % N % N %
Age 19–29 10,514 98.7 132 1.2 10 0.1 10,656 100.0 1.50E+04 <0.01
30–39 15,126 98.2 259 1.7 19 0.1 15,404 100.0
40–49 18,135 96.7 543 2.9 71 0.4 18,749 100.0
50–59 16,160 92.0 1,219 6.9 178 1.0 17,557 100.0
60–69 10,682 80.6 2,151 16.2 415 3.1 13,248 100.0
70–79 5,766 63.8 2,509 27.8 759 8.4 9,034 100.0
80–89 961 49.8 680 35.2 290 15.0 1,931 100.0
90 or higher 54 42.2 39 30.5 35 27.3 128 100.0
Marital status Married 55,932 88.0 6,230 9.8 1,421 2.2 63,583 100.0 1.70E+03 <0.01
Separated, 
divorced, widowed
5,578 81.6 952 13.9 302 4.4 6,832 100.0





2,527 62.9 1,067 26.6 423 10.5 4,017 100.0 7.90E+03 <0.01
Middle school 
graduate
8,871 74.9 2,310 19.5 666 5.6 11,847 100.0
High school 
graduate
9,046 84.7 1,365 12.8 265 2.5 10,676 100.0
College graduate 
or higher
56,954 94.7 2,790 4.6 423 0.7 60,167 100.0
Household 
income
1st quartile (lowest) 14,777 75.3 3,689 18.8 1,163 5.9 19,629 100.0 5.70E+03 <0.01
2nd quartile 25,000 90.9 2,106 7.7 396 1.4 27,502 100.0
3rd quartile 20,444 95.0 970 4.5 116 0.5 21,530 100.0
4th quartile (highest) 17,177 95.2 767 4.3 102 0.6 18,046 100.0
Residence Capital 7,417 90.6 662 8.1 105 1.3 8,184 100.0 148.40 <0.01
Urban 16,162 91.3 1,248 7.1 287 1.6 17,697 100.0
Rural 53,819 88.5 5,622 9.2 1,385 2.3 60,826 100.0
Hypertension No 63,319 91.7 4,666 6.8 1,029 1.5 69,014 100.0 2.20E+03 <0.01
Yes 14,079 79.6 2,866 16.2 748 4.2 17,693 100.0
Diabetes 
mellitus
No 71,734 90.3 6,247 7.9 1,436 1.8 79,417 100.0 1.10E+03 <0.01
Yes 5,664 77.7 1,285 17.6 341 4.7 7,290 100.0
Dyslipidemia No 70,778 89.7 6,569 8.3 1,566 2.0 78,913 100.0 168.76 <0.01
Yes 6,620 84.9 963 12.4 211 2.7 7,794 100.0
Table 1 (continued)
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Pearson χ2 P valueMild Moderate Severe
N % N % N % N %
Alcohol 
consumption
Non-drinker 13,683 80.2 2,588 15.2 787 4.6 17,058 100.0 2.70E+03 <0.01
Less than once per 
month
6,540 89.3 647 8.8 137 1.9 7,324 100.0
Once per month 5,997 92.8 401 6.2 66 1.0 6,464 100.0
2 to 4 times per 
month
20,153 94.1 1,070 5.0 203 0.9 21,426 100.0
2 to 3 times per 
week
19,389 93.1 1,242 6.0 189 0.9 20,820 100.0
4 or more times per 
week
11,636 85.5 1,584 11.6 395 2.9 13,615 100.0
Smoking Never smoker 18,394 91.6 1,394 6.9 303 1.5 20,091 100.0 1.30E+03 <0.01
Former smoker 23,016 83.8 3,567 13.0 896 3.3 27,479 100.0
Non-daily smoker 2,168 92.6 137 5.8 37 1.6 2,342 100.0
Daily smoker 33,820 91.9 2,434 6.6 541 1.5 36,795 100.0
IPSS voiding No 76,317 97.9 1,653 2.1 – 0.0 77,970 100.0 6.10E+04 <0.01
Yes 1,081 12.4 5,879 67.3 1,777 20.3 8,737 100.0
IPSS storage No 74,574 97.4 1,976 2.6 40 0.1 76,590 100.0 4.60E+04 <0.01
Yes 2,824 27.9 5,556 54.9 1,737 17.2 10,117 100.0
IPSS nocturia No 50,887 98.4 773 1.5 69 0.1 51,729 100.0 1.10E+04 <0.01
Yes 26,511 75.8 6,759 19.3 1,708 4.9 34,978 100.0
significant differences in all independent variables and 
covariates (all P<0.01).
Results of multivariable analysis on IPSS grade, voiding, 
storage, and nocturia symptoms are shown in Tables 2−5, 
respectively. Those who smoked in the past but currently 
quitted and those who were daily smokers showed 
significantly increased risk of having the worst IPSS grade 
(past smoker, OR: 1.26, 95% CI: 1.14 to 1.39, P<0.01; daily 
smoker, OR: 1.21, 95% CI: 1.10 to 1.34, P<0.01; Table 2), 
having voiding symptoms (past smoker, OR: 1.31, 95% 
CI: 1.19 to 1.45, P<0.01; daily smoker, OR: 1.31, 95% CI: 
1.18 to 1.46, P<0.01; Table 3), and having storage symptoms 
(past smoker, OR: 1.19, 95% CI: 1.08 to 1.30, P<0.01; daily 
smoker, OR: 1.13, 95% CI: 1.03 to 1.24; P=0.01; Table 4) 
compared to subjects who never smoked. Regarding 
nocturia symptoms, past smoker showed increased risk 
of having nocturia symptoms (OR: 1.09, 95% CI: 1.03 to 
1.15, P<0.01). However, daily smoker showed significantly 
decreased risk of having nocturia symptoms compared to 
subjects who were never smokers (OR: 0.79, 95% CI: 0.75 
to 0.84, P<0.01) (Table 5).
Those who drank alcohol at least once per month were 
significantly associated with decreased risk of having the 
worst IPSS grade (once per month, OR: 0.80, 95% CI: 0.68 
to 0.93, P<0.01; 2 to 4 times per month, OR: 0.72, 95% CI: 
0.65 to 0.80, P<0.01; 2 to 3 times per week, OR: 0.80, 95% 
CI: 0.72 to 0.89, P<0.01; 4 or more times per week, OR: 
0.90, 95% CI: 0.81 to 0.99, P=0.03, Table 2), having voiding 
symptoms (once per month, OR: 0.82, 95% CI: 0.70 to 0.95, 
P=0.01; 2 to 4 times per month, OR: 0.80, 95% CI: 0.72 
to 0.90, P<0.01; 2 to 3 times per week, OR: 0.79, 95% CI: 
0.71 to 0.88, P<0.01; 4 or more times per week, OR: 0.90, 
95% CI: 0.81 to 0.99, P=0.03; Table 3), and having storage 
symptoms (once per month, OR: 0.80, 95% CI: 0.69 to 0.93, 
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Table 2 Association between alcohol consumption or smoking and IPSS grade
Variables Subcategory
IPSS grade (mild, moderate, severe) (reference = mild)
OR Linearized SE P value 95% CI
Alcohol consumption Non-drinker 1.00 Ref
Less than once per month 0.96 0.06 0.52 0.84 1.09
Once per month 0.80 0.06 <0.01 0.68 0.93
2 to 4 times per month 0.72 0.04 <0.01 0.65 0.80
2 to 3 times per week 0.80 0.04 <0.01 0.72 0.89
4 or more times per week 0.90 0.04 0.03 0.81 0.99
Smoking Never smoker 1.00 Ref
Former smoker 1.26 0.06 <0.01 1.14 1.39
Non-daily smoker 1.03 0.13 0.78 0.81 1.32
Daily smoker 1.21 0.06 0.00 1.10 1.34
Threshold (moderate) – 3.26 0.17 0.00 2.93 3.58
Threshold (severe) – 5.33 0.17 0.00 5.00 5.66
The KCHS as a sample survey was analyzed by study subject and with applied weight calculated in production of the sample design 
weight and benchmark weight. Strata with single sampling unit centered at overall mean. Sample size =86,707, weighted =16,625,969. 
Model adjusted for age, marital status, education level, household income, residence, hypertension, diabetes mellitus, and dyslipidemia. 
KCHS, Korean Community Health Survey; IPSS, International Prostate Symptom Score; OR, odds ratio; CI, confidence interval; SE, 
standard error; Ref, reference.
Table 3 Association between alcohol consumption or smoking and IPSS voiding 
Variable Subcategory
IPSS voiding (yes =5 or higher) (reference = no)




Less than once per month 1.00 0.07 0.95 0.88 1.14
Once per month 0.82 0.06 0.01 0.70 0.95
2 to 4 times per month 0.80 0.04 <0.01 0.72 0.90
2 to 3 times per week 0.79 0.04 <0.01 0.71 0.88
4 or more times per week 0.90 0.05 0.03 0.81 0.99
Smoking Never smoker 1.00 Ref
Former smoker 1.31 0.07 <0.01 1.19 1.45
Non-daily smoker 1.13 0.14 0.34 0.88 1.44
Daily smoker 1.31 0.07 <0.01 1.18 1.46
The KCHS as a sample survey was analyzed by study subject and with applied weight calculated in production of the sample design 
weight and benchmark weight. Strata with single sampling unit centered at overall mean. Sample size =86,707, weighted =16,625,969. 
Model adjusted for age, marital status, education level, household income, residence, hypertension, diabetes mellitus, and dyslipidemia. 
KCHS, Korean Community Health Survey; IPSS, International Prostate Symptom Score; OR, odds ratio; CI, confidence interval; SE, 
standard error; Ref, reference. 
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Table 4 Association between alcohol consumption or smoking and IPSS storage
Variable Subcategory
IPSS Storage (yes =4 or higher) (reference = no)




Less than once per month 0.93 0.06 0.28 0.82 1.06
Once per month 0.80 0.06 0.01 0.69 0.93
2 to 4 times per month 0.77 0.04 <0.01 0.69 0.85
2 to 3 times per week 0.81 0.04 <0.01 0.74 0.90
4 or more times per week 0.95 0.05 0.32 0.87 1.05
Smoking Never smoker 1.00 Ref
Former smoker 1.19 0.06 <0.01 1.08 1.30
Non-daily smoker 1.21 0.14 0.11 0.96 1.53
Daily smoker 1.13 0.05 0.01 1.03 1.24
The KCHS as a sample survey was analyzed by study subject and with applied weight calculated in production of the sample design 
weight and benchmark weight. Strata with single sampling unit centered at overall mean. Sample size =86,707, weighted =16,625,969. 
Model adjusted for age, marital status, education level, household income, residence, hypertension, diabetes mellitus, and dyslipidemia. 
KCHS, Korean Community Health Survey; IPSS, International Prostate Symptom Score; OR, odds ratio; CI, confidence interval; SE, 
standard error; Ref, reference. 
Table 5 Association between alcohol consumption or smoking and nocturia
Variable Subcategory
IPSS Nocturia (yes =1 or higher) (reference = no)




Less than once per month 1.06 0.05 0.18 0.97 1.15
Once per month 1.08 0.05 0.10 0.99 1.18
2 to 4 times per month 1.07 0.04 0.03 1.01 1.15
2 to 3 times per week 1.13 0.04 <0.01 1.06 1.21
4 or more times per week 1.22 0.05 <0.01 1.14 1.32
Smoking Never smoker 1.00 Ref
Former smoker 1.09 0.03 <0.01 1.03 1.15
Non-daily smoker 0.95 0.06 0.40 0.83 1.08
Daily smoker 0.79 0.02 <0.01 0.75 0.84
The KCHS as a sample survey was analyzed by study subject and with applied weight calculated in production of the sample design 
weight and benchmark weight. Strata with single sampling unit centered at overall mean. Sample size =86,707, weighted =16,625,969. 
Model adjusted for age, marital status, education level, household income, residence, hypertension, diabetes mellitus, and dyslipidemia. 
KCHS, Korean Community Health Survey; IPSS, International Prostate Symptom Score; OR; odds ratio; CI, confidence interval; SE, 
standard error; Ref, reference. 
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P=0.01; 2 to 4 times per month, OR: 0.77, 95% CI: 0.69 to 
0.85, P<0.01; 2 to 3 times per week, OR: 0.81, 95% CI: 0.74 
to 0.90, P<0.01; Table 4) compared to subjects in the non-
drinker group. On the other hand, those who drank alcohol 
at least twice per month were significantly associated with 
increased risk of having nocturia symptoms compared to 
subjects in the non-drinker group (2 to 4 times per month, 
OR: 1.07, 95% CI: 1.01 to 1.15, P=0.03; 2 to 3 times per 
week, OR: 1.13, 95% CI: 1.06 to 1.21, P<0.01; 4 or more 
times per week, OR: 1.22, 95% CI: 1.14 to 1.32; Table 5). 
Discussion
The main focus of this study was to investigate relationships 
of LUTS with cigarette smoking and alcohol intake using 
large national representative population data so that more 
firmed evidence about their relationship could be obtained. 
Considering conflicting findings about their relationships, 
this study could provide supportive information by 
overcoming low population-based sample issue of previous 
studies. Our results suggest a positive role of alcohol 
drinking and a negative role of cigarette smoking on diverse 
LUTS categories including general LUTS (IPSS severity), 
storage LUTS, and voiding LUTS. The most interesting 
finding of this study is that cigarette smoking and alcohol 
intake could affect nocturia. This is a novel finding. Only 
limited literature has scope of this finding. 
Although one recent systematic review concluded that 
modest alcohol intake was a positive factor for male LUTS 
as it decreased the risk of LUTS compared to non-drinking 
as moderate alcohol intake was associated with decreased 
risk of BPH diagnosis and undergoing surgery (2), 
two large longitudinal prospective studies showed opposite 
findings (6,7). One study showed that daily alcohol 
drinking had no effect on LUTS severity in their 4-year 
follow-up study (6) while another study showed a positive 
effect of alcohol drinking on LUTS severity in their 7-year 
follow-up study (7). However, heavy alcohol intake had 
negative effect on LUTS including incontinence, voiding, 
and storage LUTS (4). This J-shaped association between 
alcohol intake and LUTS severity was also found in a large 
population study (8). It reported that the risk for moderate 
and severe LUTS was the lowest in modest drinkers but the 
highest in heavy drinkers compared to non-drinkers (8). 
Our study showed a positive effect of alcohol intake on 
LUTS severity by IPSS grade. Not only moderate drinkers, 
but also heavy drinkers (alcohol consumption: 4 or more 
times per week) showed significantly reduced risk for LUTS 
severity. Alcohol intake also had positive effects on voiding 
LUTS and storage LUTS. Among LUTS, association 
between alcohol intake and OAB showed more inconsistent 
results that that between alcohol intake and general LUTS. 
In two large population studies, one study showed negative 
role of alcohol intake in OAB (9) while the other study did 
not show any association (10). In our study, alcohol intake 
showed a positive role in storage LUTS by IPSS, even 
heavy drinkers showed decreasing OR for storage LUTS, 
although the decrease was not statistically significant. 
There are only a few studies about the relationship 
between alcohol intake and nocturia. One cohort study 
showed no association between alcohol intake and nocturia (9). 
However, another study showed that modest alcohol intake 
was associated with lower risk of nocturia (11). In our study, 
alcohol intake showed negative effect of any level of drinking 
on nocturia. All results were statistically significant findings 
compared to non-alcohol drinkers. Our study is the first one 
to show a negative effect of alcohol intake on nocturia.
Possible mechanisms for the relationship between 
alcohol intake and LUTS include increased sympathetic 
tone activity, diuretic effect, and changed androgen levels 
(12,13). Positive effect of alcohol intake on LUTS could be 
explained by diuretic effect and low androgen level while 
negative effect could be explained by diuretic effect and 
increased sympathetic tone activity. Diuretic effect could 
serve as both positive and negative factor in the effect of 
alcohol intake on LUTS. Individual differences in genetic 
polymorphism of the aldehyde dehydrogenase 2 (ALDH2) 
gene might also have associations with BPH (14).
The relationship between cigarette smoking and LUTS 
has more limited evidence than that between alcohol and 
LUTS. Several studies have shown a negative effect of 
cigarette smoking on LUTS (2), although other studies 
have shown no association between the degree of smoking 
and LUTS (12,15). In our study, cigarette smoking showed 
negative effect on all LUTS except nocturia. The degree of 
smoking was also related to the severity of LUTS in that it 
had negative effects on all LUTS except nocturia. 
The possible mechanism for the effect of cigarette 
smoking on LUTS has been investigated in many 
experimental studies. These studies have suggested that 
cigarette smoking could increase androgen level (16,17), 
increase the sympathetic tone activity by nicotine receptor 
(18,19), and cause imbalance in hormone and nutrient 
between muscle and collagen (20). Other studies support 
that the negative effect of cigarette smoking on nocturia is 
especially related to metabolic syndrome (21). However, 
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Bing et al. (22) in their Danish population study reported 
that smoking was inversely associated with nocturia in 
both crude and adjusted models. Although significance 
disappeared compared to severe nocturia of ≥2 or ≥3 voids 
per night, the significance appeared in the ordinal logistic 
model. Seim et al. (23) have also reported an inverse 
association between smoking and nocturia, supporting 
a positive or protective effect of smoking on nocturia. 
Although we could not adjust metabolic syndrome factor, 
smoking was inversely associated with nocturia after 
adjustment of possible covariates including body mass index 
(BMI). This protective effect of smoking could be explained 
by increased arginine vasopressin due to increased nicotine, 
thus decreasing nocturnal urine production (24,25).
Although we have performed a thorough analysis, this 
study still has several limitations. First, cross-sectional study 
design hampered the establishment of a causal effect of 
alcohol intake or cigarette smoking on the severity of LUTS. 
Second, subjective questionnaire was used to access the 
degree of alcohol intake and cigarette smoking. However, 
estimating the degree of drinking and smoking without 
questionnaire is difficult. Lastly, these data did not include 
biological data including prostate size or chemistry profiles. 
They did not include objective measurement of LUTS such 
as uroflowmetry or frequency volume chart either.
Conclusions
This large population-based study suggests updated 
evidence about relationships of LUTS with alcohol intake 
and cigarette smoking. Alcohol showed positive effect on 
LUTS except nocturia whereas cigarette smoking had 
negative effect on LUTS except nocturia. Alcohol increased 
the risk of nocturia while smoking decreased the risk of 
nocturia. Further evidence using prospective trial is needed 
to support our study findings. 
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